V. Kelly

403 total citations
13 papers, 301 citations indexed

About

V. Kelly is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, V. Kelly has authored 13 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in V. Kelly's work include Lung Cancer Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Neutropenia and Cancer Infections (2 papers). V. Kelly is often cited by papers focused on Lung Cancer Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Neutropenia and Cancer Infections (2 papers). V. Kelly collaborates with scholars based in United Kingdom, Australia and United States. V. Kelly's co-authors include S.M. O'Reilly, Peter Clark, David B. Smith, Helen Innes, M. C. Genovese, E. Marshall, C. Peedell, N. O’Rourke, R. McMenemin and M. Snee and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

V. Kelly

12 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Kelly United Kingdom 6 188 96 68 57 36 13 301
Linda C. Steelhammer United States 6 97 0.5× 248 2.6× 33 0.5× 14 0.2× 9 0.3× 7 348
Claudio Flores Peru 11 278 1.5× 136 1.4× 16 0.2× 32 0.6× 8 0.2× 41 493
Alberto Arcediano Spain 9 229 1.2× 101 1.1× 53 0.8× 61 1.1× 15 341
J. Shogan United States 4 443 2.4× 53 0.6× 55 0.8× 271 4.8× 3 0.1× 6 511
Luciana GO Clark Brazil 6 239 1.3× 59 0.6× 42 0.6× 91 1.6× 8 352
Kevin Imrie Canada 11 140 0.7× 36 0.4× 8 0.1× 11 0.2× 4 0.1× 16 332
H. G. Fuhr Germany 7 215 1.1× 69 0.7× 40 0.6× 16 0.3× 17 310
Michael Keng United States 11 182 1.0× 27 0.3× 57 0.8× 26 0.5× 1 0.0× 52 453
Gilles Freyer France 8 167 0.9× 39 0.4× 19 0.3× 50 0.9× 21 248
Andriy Krendyukov Germany 13 270 1.4× 22 0.2× 29 0.4× 131 2.3× 53 417

Countries citing papers authored by V. Kelly

Since Specialization
Citations

This map shows the geographic impact of V. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Kelly more than expected).

Fields of papers citing papers by V. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Kelly. The network helps show where V. Kelly may publish in the future.

Co-authorship network of co-authors of V. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of V. Kelly. A scholar is included among the top collaborators of V. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Kelly. V. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Friedman, Gregory K., Li Nan, V. Kelly, et al.. (2014). γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia. Gene Therapy. 22(4). 348–355. 29 indexed citations
2.
3.
4.
Kelly, V. & M. C. Genovese. (2013). Novel small molecule therapeutics in rheumatoid arthritis. Lara D. Veeken. 52(7). 1155–1162. 32 indexed citations
5.
Kelly, V., et al.. (2013). β-ALANINE SUPPLEMENTATION AND SIDE EFFECTS; INFLUENCE OF BODY COMPOSITION. British Journal of Sports Medicine. 47(17). e4.49–e4. 4 indexed citations
6.
Kelly, V., et al.. (2013). EVALUATION OF THE PREVALENCE, KNOWLEDGE AND ATTITUDES RELATING TO β-ALANINE USE AMONG ATHLETES. British Journal of Sports Medicine. 47(17). e4.29–e4. 3 indexed citations
7.
Maguire, J., N. O’Rourke, C. Peedell, et al.. (2012). S95 SOCCAR: Internationally Resonant Results from a Randomised Trial Based on UK Clinical Practise. Thorax. 67(Suppl 2). A47.1–A47. 3 indexed citations
8.
Brümmendorf, Tim H., Jörge E. Cortes, Hagop M. Kantarjian, et al.. (2011). Bosutinib (BOS) as third-line therapy for chronic phase (CP) chronic myeloid leukemia (CML) following failure with imatinib (IM) and dasatinib (DAS) or nilotinib (NIL).. Journal of Clinical Oncology. 29(15_suppl). 6535–6535. 5 indexed citations
9.
Maguire, J., V. Kelly, C. Smyth, M.J. Ledson, & Martin Walshaw. (2010). P213 Long term results of concurrent chemotherapy and hypofractionated radiotherapy for inoperable NSCLC. Thorax. 65(Suppl 4). A167–A167.
10.
11.
Kelly, V., et al.. (2001). Outpatient Follow-up After Treatment for Early Breast Cancer: Updated Results After 5 Years. Clinical Oncology. 13(3). 187–194. 23 indexed citations
12.
Marshall, Ernest, et al.. (2000). Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients. Supportive Care in Cancer. 8(3). 198–202. 10 indexed citations
13.
Philips, Jeanette, et al.. (1982). Percutaneous thoracic aspiration needle biopsies. Pathology. 14(2). 211–213. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda C. Steelhammer Breakdown of academic impact, for papers by Claudio Flores Breakdown of academic impact, for papers by Alberto Arcediano Breakdown of academic impact, for papers by J. Shogan Breakdown of academic impact, for papers by Luciana GO Clark Breakdown of academic impact, for papers by Kevin Imrie Breakdown of academic impact, for papers by H. G. Fuhr Breakdown of academic impact, for papers by Michael Keng Breakdown of academic impact, for papers by Gilles Freyer Breakdown of academic impact, for papers by Andriy Krendyukov
Rankless by CCL
2026